10th
Congress of the European Society of Contraception
| Scientific
programme in detail |
|||
| Wednesday,
April 30 |
Thursday,
May 1 |
Friday,
May 2 |
Saturday,
May 3 |
overview>>>
| 08:30 – 10:00 | 10:30
– 12:00 |
12:30 –
13:30 |
14:00 –
15:30 |
16:00 – 18:00 |
| 10:30 –
12:00 |
Congress
Hall |
Sponsored
Symposium 1 (Bayer Schering Pharma) : Thepremenstrual symptomatology from different angles |
|
| Chair: S. O’Brien (United Kingdom) | |||
| 10:30 | Etiology, diagnostic and treatment rationale:
International consensus on PMS/PMDD – S. O’Brien (United Kingdom) |
||
| 11:00 | PMS/PMDD in real life – A. Schwenkhagen (Germany) | ||
| 11:30 | A new oral contraceptive with two additional
indications – experiences from the United States – L. Schulman (USA) |
||
|
|||
| 10:30 –
12:00 |
Meeting
Hall 1 |
Congress
Session 1: Critical evaluation and clinical management of side effects |
|
| Chair: D. Cibula (Czech Rep.) – K. Sedlecki
(Serbia) |
|||
| Book of abstracts | |||
| 10:30 | Mood changes/depression – R. Van
Lunsen (The Netherlands) |
IS-04 | |
| 10:50 | Weight changes – M. Lech (Poland) | IS-05 | |
| 11:10 | Bone Mineral Density (BMD) – D. Cibula
(Czech Rep.) |
IS-06 | |
| 11:30 | Breakthrough bleeding – tbd | IS-07 | |
| 11:45 | How often and why do women discontinue their
contraceptive method? Results from a French population-based survey – C. Moureau (France) |
FC-01 | |
| 11:53 | Comparison of patients from high risk population with vs.
without thrombotic events while exposed to hormonal contraception – M.J. Carvalho (Portugal) |
FC-02 | |
10:30 –
12:00
Panorama
Hall
Session 1: Faculty of Sexual and Reproductive Healthcare (FSRH – UK)
European
Contraception Masterclass – Transnational Evidence-Based Contraceptive
Practice
Chair: A. Glasier (UK) – C. Wilkinson (UK)
Book of abstracts
10:30
Opening remarks by the FSRH President
– M. Kishen (UK)
10:40
Depo-Provera and bone density – D.
Mansour (UK)
SS1-01
11:00
Intra-uterine devices and infection risk
– F. Martinez (Spain) – E. Lopez Arregui (Spain)
SS1-02
11:20
Emergency contraception – over the
counter and advance supplies – I. Batar (Hungary)
SS1-03
11:40
WHO-Medical eligibility criteria in the UK – A. Kubba (UK)
SS1-04
Concluding remarks from the Chairpersons
10:30 –
12:00
Hall
IV
Communication Session 1
Chair: P. Kascak (Slovakia) – D. Apter (Finland)
Book of abstracts
10:30
Review of emergency re-admissions after 1st trimester
abortion; Implications for service design and delivery – O. Graham
(UK)
FC-03
10:43
Which women are at risk for repeated abortion? – S.
Tschudin (Switzerland)
FC-04
10:56
Widening access for practitioners in Scotland to Sexual
and Reproductive Health education through e-learning delivery: could
this be developed for use in other countries? – N. Graham (UK)
FC-05
11:09
Ten years of medical abortion services and innovations in
Tunisia – S. Hajri (Tunisia)
FC-06
11:22
How do men with subnormal semen values react to hormonal
male contraception? – E. Nieschlag (Germany)
FC-07
11:35
Contraceptive failure related to early ovulation – E.
Wiebe (Canada)
FC-08
11:48
Supporting primary healthcare professionals providing
crisis pregnancy care in Ireland – N. Kenny (Ireland)
FC-09
10:30 –
12:00
Club E
Session 2: Association of Reproductive Health Professionals (ARHP – USA)
Translating
science into practice: helping patients understand health risks for
effective, customized care
Co-moderators: L. Shulman (USA), A. Furedi (UK)
Book of abstracts
10:30
Opening remarks by the ARHP board chair
– L. Shulman (USA)
10:40
You decide: making informed health choices
about hormonal contraception – Co-Moderators
SS2-01
11:10
Translating the scientific literature on
contraception into effective patient care – Co-Moderators
SS2-02
11:40
Questions, answers, interactive discussion
– Co-Moderators
| Scientific
programme in detail |
|||
| Wednesday,
April 30 |
Thursday,
May 1 |
Friday,
May 2 |
Saturday,
May 3 |
| 08:30 – 10:00 | 10:30
– 12:00 |
12:30 –
13:30 |
14:00 –
15:30 |
16:00 – 18:00 |
|
complete final announcement (1,509 mB) |
|
